Olivier Lambotte

31.2k total citations · 7 hit papers
240 papers, 13.9k citations indexed

About

Olivier Lambotte is a scholar working on Immunology, Virology and Oncology. According to data from OpenAlex, Olivier Lambotte has authored 240 papers receiving a total of 13.9k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Immunology, 90 papers in Virology and 58 papers in Oncology. Recurrent topics in Olivier Lambotte's work include HIV Research and Treatment (89 papers), Immune Cell Function and Interaction (71 papers) and Cancer Immunotherapy and Biomarkers (43 papers). Olivier Lambotte is often cited by papers focused on HIV Research and Treatment (89 papers), Immune Cell Function and Interaction (71 papers) and Cancer Immunotherapy and Biomarkers (43 papers). Olivier Lambotte collaborates with scholars based in France, United States and Spain. Olivier Lambotte's co-authors include Paul Coppo, Lionel Galicier, L. Fardet, Jean‐François Delfraissy, Christophe Marzac, Cédric Aumont, Aurélien Marabelle, Faroudy Boufassa, Stéphane Champiat and Jean‐Marie Michot and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Olivier Lambotte

230 papers receiving 13.7k citations

Hit Papers

Microbial translocation i... 2006 2026 2012 2019 2006 2020 2014 2016 2007 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Microbial translocation is a cause of systemic immune activation in chronic HIV infection
    2006 2.7k citations Olivier Lambotte et al. profile →
  2. Immune-related adverse events of checkpoint inhibitors
    2020 931 citations Olivier Lambotte, Xavier Mariette et al. profile →
  3. Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome
    2014 868 citations Olivier Lambotte et al. profile →
  4. Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
    2016 813 citations Olivier Lambotte, Aurélien Marabelle et al. profile →
  5. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
    2007 451 citations Asier Sáez‐Cirión, Christine Lacabaratz et al. Proceedings of the National Academy of Sciences profile →
  6. Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors
    2018 376 citations Eléonora De Martin, Jean‐Marie Michot et al. profile →
  7. Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer
    2019 272 citations Jean‐Marie Michot, Jérôme Le Pavec et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivier Lambotte France 56 5.9k 5.0k 3.8k 3.5k 2.4k 240 13.9k
Ronald T. Mitsuyasu United States 48 3.3k 0.6× 4.2k 0.8× 2.6k 0.7× 3.0k 0.9× 2.4k 1.0× 178 10.3k
Savita Pahwa United States 54 5.4k 0.9× 4.7k 0.9× 2.9k 0.8× 998 0.3× 3.3k 1.4× 360 10.9k
Brigitte Autran France 65 7.2k 1.2× 8.5k 1.7× 5.8k 1.5× 1.4k 0.4× 4.5k 1.9× 307 15.8k
Henry H. Balfour United States 60 2.4k 0.4× 3.8k 0.8× 6.0k 1.6× 3.5k 1.0× 7.4k 3.1× 229 15.2k
Dorothy H. Crawford Australia 64 3.5k 0.6× 2.3k 0.5× 2.6k 0.7× 6.0k 1.7× 5.7k 2.4× 318 17.4k
Stéphane Blanche France 52 2.2k 0.4× 2.8k 0.6× 5.1k 1.4× 929 0.3× 2.8k 1.1× 254 9.6k
Stig S. Frøland Norway 58 4.6k 0.8× 1.2k 0.2× 1.1k 0.3× 1.2k 0.3× 2.3k 1.0× 225 11.5k
C Griscelli France 63 7.1k 1.2× 1.5k 0.3× 2.7k 0.7× 1.4k 0.4× 2.3k 0.9× 317 13.0k
Jean‐François Delfraissy France 53 3.3k 0.6× 5.7k 1.1× 5.2k 1.4× 575 0.2× 2.7k 1.1× 193 10.2k
Irini Sereti United States 49 2.9k 0.5× 3.6k 0.7× 3.1k 0.8× 954 0.3× 2.6k 1.1× 212 8.2k

Countries citing papers authored by Olivier Lambotte

Since Specialization
Citations

This map shows the geographic impact of Olivier Lambotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Lambotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Lambotte more than expected).

Fields of papers citing papers by Olivier Lambotte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Lambotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Lambotte. The network helps show where Olivier Lambotte may publish in the future.

Co-authorship network of co-authors of Olivier Lambotte

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Lambotte. A scholar is included among the top collaborators of Olivier Lambotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Lambotte. Olivier Lambotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laparra, Ariane, Stéphane Champiat, François‐Xavier Danlos, et al.. (2025). Immune-related adverse events occurring rapidly after a single dose of immune checkpoint blockade. Journal for ImmunoTherapy of Cancer. 13(9). e012756–e012756.
2.
Lambotte, Olivier, et al.. (2024). Fatal Immune-mediated Myocarditis Mimicking Infiltrative Cardiomyopathy in a 54-year-old Woman with Metastatic Melanoma: A Case Report. Journal of Cardiovascular Magnetic Resonance. 26. 100855–100855.
3.
Laparra, Ariane, François‐Xavier Danlos, Antoine Hollebecque, et al.. (2023). Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology. European Journal of Cancer. 193. 113313–113313. 11 indexed citations
4.
5.
Marlin, Romain, Thierry Lazure, Pauline Maisonnasse, et al.. (2022). Detection of SARS-CoV-2 in subcutaneous fat but not visceral fat, and the disruption of fat lymphocyte homeostasis in both fat tissues in the macaque. Communications Biology. 5(1). 542–542. 9 indexed citations
6.
Ferlicot, Sophie, L. Rocher, Florent L. Besson, et al.. (2022). Renal involvement of lymphomas proven by kidney biopsy: report of 10 cases from a tertiary care center and comparison with the literature. International Journal of Hematology. 116(5). 678–695. 1 indexed citations
7.
Desjardins, Delphine, Asier Sáez‐Cirión, Aurélie Barrail‐Tran, et al.. (2022). Prolonged Antiretroviral Treatment Induces Adipose Tissue Remodelling Associated with Mild Inflammation in SIV-Infected Macaques. Cells. 11(19). 3104–3104. 6 indexed citations
8.
Kfoury, Maria, Anne-Laure Voisin, Stéphane Champiat, et al.. (2022). Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias. Cancer Treatment Reviews. 110. 102452–102452. 35 indexed citations
9.
Benítez, José Carlos, Bastien Job, Vincent de Montpréville, et al.. (2021). Cancer activation pathways of thymic epithelial tumors (TETs) by targeted gene expression analysis.. Journal of Clinical Oncology. 39(15_suppl). 8575–8575. 3 indexed citations
10.
Allenbach, Yves, C. Anquetil, Ali Manouchehri, et al.. (2020). Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities. Autoimmunity Reviews. 19(8). 102586–102586. 96 indexed citations
11.
Baldini, Capucine, P. Martin Romano, Anne-Laure Voisin, et al.. (2020). Impact of aging on immune-related adverse events generated by anti–programmed death (ligand)PD-(L)1 therapies. European Journal of Cancer. 129. 71–79. 63 indexed citations
12.
Aldea, Mihaela, Laura Mansi, Aurélien Marabelle, et al.. (2020). How to manage patients with corticosteroids in oncology in the era of immunotherapy?. European Journal of Cancer. 141. 239–251. 64 indexed citations
13.
Gorwood, Jennifer, Christine Bourgeois, Cindy Rose, et al.. (2020). SIV Infection and the HIV Proteins Tat and Nef Induce Senescence in Adipose Tissue and Human Adipose Stem Cells, Resulting in Adipocyte Dysfunction. Cells. 9(4). 854–854. 22 indexed citations
14.
Hocini, Hakim, Henri Bonnabau, Christine Lacabaratz, et al.. (2019). HIV Controllers Have Low Inflammation Associated with a Strong HIV-Specific Immune Response in Blood. Journal of Virology. 93(10). 29 indexed citations
15.
Chaix, Marie‐Laure, Faroudy Boufassa, Marianne Leruez‐Ville, et al.. (2017). Detectable HIV-RNA in semen of HIV controllers. PLoS ONE. 12(8). e0183376–e0183376. 8 indexed citations
16.
Noël, Nicolas, Elina Teicher, Yann Quertainmont, et al.. (2016). Recurrent obstructive acute pyelonephritis: A rare form of Actinotignum (Actinobaculum) schaalii infection in a HIV-1 infected patient. Anaerobe. 43. 75–77. 5 indexed citations
17.
Noël, Nicolas, Félix Ackermann, Jérôme Le Pavec, et al.. (2015). Life-threatening Hughes-Stovin syndrome: The Yin and Yang of anticoagulation therapy. Joint Bone Spine. 83(4). 459–460. 3 indexed citations
18.
Sáez‐Cirión, Asier, Christine Lacabaratz, Olivier Lambotte, et al.. (2007). HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proceedings of the National Academy of Sciences. 104(16). 6776–6781. 451 indexed citations breakdown →
19.
Lambotte, Olivier & J. F. Delfraissy. (2006). Les « HIV controllers » : un groupe homogène de patients infectés par le VIH avec un contrôle spontané de la réplication virale. Pathologie Biologie. 54(10). 566–571. 5 indexed citations
20.
Lambotte, Olivier, Moana Gelu‐Siméon, G. Maigné, et al.. (2004). Pegylated interferon alpha-2a-associated life-threatening Evans' syndrome in a patient with chronic hepatitis C. Journal of Infection. 51(3). e113–e115. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronald T. Mitsuyasu Breakdown of academic impact, for papers by Savita Pahwa Breakdown of academic impact, for papers by Brigitte Autran Breakdown of academic impact, for papers by Henry H. Balfour Breakdown of academic impact, for papers by Dorothy H. Crawford Breakdown of academic impact, for papers by Stéphane Blanche Breakdown of academic impact, for papers by Stig S. Frøland Breakdown of academic impact, for papers by C Griscelli Breakdown of academic impact, for papers by Jean‐François Delfraissy Breakdown of academic impact, for papers by Irini Sereti
Rankless by CCL
2026